The Paediatric Gliomas Drugs market was valued at USD 1.02 Billion in 2022 and is expected to reach USD 1.70 Billion by 2023, growing at a CAGR of 6.5% (2023-2023). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.